Description

DULOSIGN 30 CAP is a centrally acting antidepressant and pain modulator that contains Duloxetine 30 mg, a serotonin-norepinephrine reuptake inhibitor (SNRI). It is widely prescribed for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic peripheral neuropathy, and fibromyalgia.

Duloxetine increases the levels of serotonin and norepinephrine in the brain, improving mood, emotional balance, and pain perception. The 30 mg dose is typically used for initial treatment or for patients requiring a lower starting dose.

Therapeutic Uses:

• Major depressive disorder (MDD)

• Generalized anxiety disorder (GAD)

• Chronic musculoskeletal pain

• Diabetic peripheral neuropathic pain

• Fibromyalgia and chronic fatigue syndrome

• Stress urinary incontinence (off-label)

Key Benefits:

• Dual action on mood and chronic pain

• Well-tolerated with once-daily dosing

• Lower dose ideal for new patients or elderly use

• Reduces emotional distress and physical pain together

• Helps manage nerve pain without opioids

Manufactured in WHO-GMP and ISO-certified facilities, DULOSIGN 30 CAP is exported worldwide by BLUEPILL EXPRESS, a globally trusted pharmaceutical exporter. BLUEPILL EXPRESS supplies high-quality antidepressant and pain-relief formulations to markets across Asia, Africa, Europe, Latin America, and the Middle East, ensuring full regulatory compliance and consistent export support.